Our findings could potentially be extrapolated to other hematological malignancies and solid tumors where the SDF1/CXCR4 axis plays a role in disease progression and metastasis, such as lymphomas, multiple myeloma, and breast cancer. This evidence concerns the gene CXCL12 and AL amyloidosis.